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Abstract
Purpose. – The current paper focused on the validity of using self-reports to assess emotion regulation abilities in autism spectrum
disorders (ASD). To assess this we sought responses to two alexithymia self-reports and a depression self-report at two time points from adults
with and without ASD.
Materials and methods. – An initial sample of 27 adults with ASD and 35 normal adults completed the 20-item Toronto alexithymia scale
(TAS-20), the Bermond and Vorst alexithymia questionnaire-form B (BVAQ-B), and the Beck depression inventory (BDI), at test time 1. Of
these individuals, 19 ASD and 29 controls participated again after a period ranging from 4 to 12 months.
Results. – ASD participants were able to report about their own emotions using self-reports. BVAQ-B showed reasonable convergent
validity and test–retest reliability in both groups. Scores on both alexithymia scales were stable across the two participant groups. However,
results revealed that although the TAS-20 total score discriminated between the two groups at both time points, the BVAQ-B total score did
not. Moreover, the TAS-20 showed stronger test–retest reliability than the BVAQ-B.
Conclusion. – ASD participants appeared more depressed and more alexithymic than the controls. The use of the BVAQ-B, as an addi-
tional assessment of alexithymia, indicated that ASD patients have a specific type of alexithymia characterised by increased difficulties in the
cognitive domain rather than the affective aspects of alexithymia.
© 2004 Elsevier SAS. All rights reserved.
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1. Introduction
Individuals with autism spectrum disorders (ASD) are gen-
erally considered to have difficulty in processing their own
and other people’s emotions [4,12,18]. A current theory of
the social communication impairments in ASD proposes that
there is an impairment in theory-of-mind, also referred to as
‘mentalising’. By this, it is meant the ability to attribute men-
tal states automatically to others and to implicitly take account
of the fact that different people have different thoughts [5,6].
This impairment may cause an inability to identify and
describe one’s own mental states, including feelings about
things.Autobiographies of apparently well-compensated indi-
viduals with ASD suggest some unusual reporting of own
feelings, in conjunction with very detailed reporting of bodily
sensations (e.g. [13,14]).
In a separate literature on disorders of emotion regulation,
Sifnéos (1973) described a cluster of cognitive and affective
features in terms of the alexithymia construct [26]. In this
case, emotion dysregulation includes difficulties in identify-
ing and describing feelings, difficulties in distinguishing feel-
ings from the bodily sensations of emotional arousal, impaired
symbolisation, as evidenced by a paucity of fantasies and other
imaginative activity, and a tendency to focus on external events
rather than inner experiences (concrete thought). Alexithymia
has been investigated in various psychiatric populations (see
[28] for a recent review), mostly using the Toronto alexithymia
scales (TAS-26 and TAS-20 [2,3,29]), notably because these
self-reports are the most validated instruments aimed at
assigning alexithymia and because they are the easiest to use
[1].
Recently the possibility of using self-report measures to
understand adults with high-functioning ASD has proved
promising. Baron-Cohen and colleagues have developed a
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number of self-report measures to be used in such adults. One
is a self-administered instrument for measuring the degree to
which an adult with normal intelligence has the traits associ-
ated with the autism spectrum (autism spectrum quotient,
[7]). This scale has been reported to have good test–retest and
inter–rater reliability and is reported to be a valuable instru-
ment for quantifying, where an individual is placed on the
spectrum between autism and normality. In addition, Baron-
Cohen and colleagues have developed the systemising quo-
tient and empathising quotient [8]. These are self-report
measures suitable for high-functioning ASD adults, which
tap the drive to analyse or construct systems and the ability to
empathise respectively.
In an earlier study we assessed levels of alexithymia and
depression at the time of testing in a group of high-
functioning ASD adults [17]. We reported the responses of
27 ASD adults, 35 controls and 49 relatives of people with
ASD on two self-report measures: the TAS-20 and the Beck
depression inventory (BDI) [9]. We believe this was the first
study to address directly the issue of the existence of emotion
processing difficulties and their relation to depression by
asking high-functioning adults with ASD to report their own
emotional processes. The ASD participants had higher al-
exithymia scores and were more depressed than a control
group matched for age and gender. This study gave some
encouragement to the view that such individuals are capable
of responding adequately to questionnaires when asked to
report their own emotions. This view has also been main-
tained through the use of Baron-Cohen et al.’s empathising
quotient [8].
While the results of our first study were promising, a need
for further investigation is evident. In particular, the outcome
of responses to alexithymia measurement, first by demon-
strating whether deficits in emotion regulation are stable over
time in ASD and second by establishing whether the deficits
can be identified when another alexithymia self-report scale
is administered.
In our original study, participants completed the Ber-
mond–Vorst alexithymia questionnaire (BVAQ) in addition
to the TAS-20. However, since little is known about the
validity and reliability of this scale, we did not report our
findings. In the present study, we report the responses of the
original sample on the BVAQ, as well as a follow-up of this
sample in which 19 of the adults with ASD and 29 normal
controls completed both alexithymia measures (TAS-20 and
BVAQ) and the BDI. These data were collected at two time
points to assess further the validity of self-reports in a high-
functioning sample of adults with ASD, as well as the valid-
ity and reliability of the use of these scales in an ASD sample.
2. Materials and methods
2.1. Participants
Sixty-two individuals participated in our study at test time
1. This group comprised 27 adults with ASD and 35 normal
adult controls. The adults with ASD had all received a formal
diagnosis of either Asperger syndrome (n = 20) or autism
(n = 7). At test time 2, 19 adults with ASD (13 with a formal
diagnosis of Asperger syndrome, and six with a diagnosis of
autism) and 29 normal adult controls participated. Since to
complete the studies it was necessary to read and write and
indeed to complete three questionnaires unaided, all partici-
pants had to be high-functioning. These adults with ASD
were recruited via various support groups and community
centres. All had attended mainstream school, and the major-
ity of both groups reported attending further or higher edu-
cation. The control group was recruited from the subject pool
at the Institute of Cognitive Neuroscience and from local
community centres. Participant details are shown in Table 1.
2.1.1. Measures
2.1.1.1. Alexithymia. Several measures of alexithymia have
been developed, including interviewer-rated questionnaires,
projective techniques, verbal content analysis, self-report
scales, and a technique derived from cognitive science. How-
ever, only a few were devised with the aim of validating the
construct and most of them suffer from various methodologi-
cal flaws or lack of adequate validation data [1,15,20]. One
exception is the TASs, which demonstrated psychometric
properties superior to those of other alexithymia question-
naires. Originally, the TAS was designed as a 26-item scale,
clustered into four factors that were theoretically congruent
with the alexithymia construct [29]. However, a revised ver-
sion was introduced, notably because one factor (daydream-
ing) was found to have little theoretical coherence with the
other facets of the alexithymia construct. Thus, a new 20-
item version was developed (TAS-20), excluding items as-
sessing daydreaming and/or imaginal activity because of low
corrected item-total correlations and/or high correlations
with a measure of social desirability [2,3]. The TAS-20
demonstrated good internal consistency (Cronbach’s al-
pha = 0.81) and test–retest reliability over a 3-week interval
(r = 0.77), and a three-factor structure. The three factors of
this revised scale relate to: (1) ability to identify feelings, (2)
ability to describe feelings, (3) externally oriented thinking.
The number of items per factor is seven, five, and eight items,
respectively (see Table 2 for examples of items in each
factor). Five items are negatively keyed. Although the
TAS-20 does not measure alexithymia as it was originally
conceptualised [27], it has become the most widely used
instrument.
Recently, the BVAQ was developed. The development of
this scale has been grounded in both theoretical and empiri-
cal domains [31]. The questionnaire is available in Dutch,
English, French, Italian, Spanish, German, Polish and Rus-
sian. The BVAQ has two parallel versions (A and B), of
20-items each, and an extended test (A + B) of 40-items. This
instrument, which has five factors, seems to have adequate
psychometric properties but further validation is needed
[26,28,29]. The BVAQ-B has been found to provide better
psychometric properties than the BVAQ-A [11,23,32].
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The BVAQ-B consists of five subscales: (1) verbalising,
(2) fantasising, (3) identifying, (4) emotionalising, (5) anal-
ysing (see Table 2 for examples of items in each subscale).
Each subscale is comprised of four items. Half of the items
are negatively keyed. Subscales 1, 3 and 5 of the BVAQ-B
correspond to subscales 2, 1 and 3, respectively, of the TAS-
20. The two additional subscales correspond to: the degree to
which someone is inclined to fantasise, imagine and day-
dream (2. fantasising); and the degree to which someone is
emotionally aroused by emotion inducing events (4. emo-
tionalising) [31].
In view of the differences in the number of factors of the
two scales, we followed the methodology reported by Vorst
and Bermond and computed three total scores based on the
BVAQ-B subscales [31]. The standard total score equals the
sum of all five subscales (BVAQ-B total). The second total
score, labelled ‘cognitive’ score, corresponds to the sum of
the scores on three subscales (identifying, verbalising, anal-
ysing). This cognitive score should be comparable to the total
score of the TAS-20. The third total score, labelled ‘affective’
score, corresponds to the sum of the scores on the two
remaining subscales (emotionalising, fantasising).
The TAS-20 and the BVAQ-B are self-report question-
naires. In both cases, the items are rated on a five-point Likert
scale ranging from 1 (strongly disagree) to 5 (strongly agree).
For the BVAQ-B, we inversed the original method of scoring
Table 1
Mean (S.D.) total scores on the BVAQ-B, TAS-20 and BDI as well as on the BVAQ-B cognitive and affective scores and the subscale scores for the BVAQ-B and
TAS-20. Participant details are also given.
ASD adults Control group
Time 1, n = 27 Time 2, n = 19 Time 1, n = 35 Time 2, n = 29
% male 55.56 63.20 45.71 37.30
CA (years) 35.07 (12.26) 38.21 (12.55) 32.18 (11.25) 33.76 (11.81)
% in education post-16 years 81.48 89.47 94.29 96.55
BDI a (max = 63) 13.78 (6.89) 12.16 (8.47) 5.74 (4.78) 5.93 (6.06)
BVAQ-B total (max = 100) 51.26 (12.26) 51.47 (9.50) 44.57 (8.21) 45.66 (9.74)
Range (20–100) 26–79 29–71 29–61 30–64
Poor verbalising (max = 20) 11.93 (3.29) 11.84 (3.4) 9.78 (2.57) 9.0 (2.78)
Poor fantasies (max = 20) 9.70 (3.5) 10.47 (3.92) 9.54 (3.67) 10.59 (2.96)
Poor insight (max = 20) 11.26 (3.65) 10.89 (3.3) 9.77 (2.98) 9.41 (3.63)
Poor emotional excitability (max = 20) 9.59 (3.81) 9.00 (2.49) 8.86 (2.51) 9.31 (2.84)
Concrete thinking (max = 20) 8.78 (3.38) 9.26 (3.62) 7.06 (2.27) 7.0 (2.46)
BVAQ-B cognitive score (max = 60) 31.96 (9.03) 32.0 (7.02) 26.17 (5.22) 24.41 (6.49)
BVAQ-B affective score (max = 40) 19.3 (5.63) 19.47 (4.39) 18.4 (5.39) 19.9 (4.34)
TAS-20 total (max = 100) 60.44 (10.84) 59.74 (13.74) 42.51 (9.09) 38.93 (9.28)
Range (20–100) 33–82 36–87 25–59 20–55
Diffıculty identifying feelings (max = 35) 20.93 (5.73) 21.05 (7.4) 15.11 (5.27) 13.72 (5.16)
Diffıculty describing feelings (max = 25) 17.59 (3.4) 17.58 (4.72) 11.71 (3.49) 11.17 (3.59)
Externally oriented thinking (max = 40) 21.93 (6.28) 21.11 (5.8) 15.69 (4.47) 15.72 (5.03)
a Note that data for one ASD adult were not available at time point 1.
Table 2
Examples of items for each subscale of the TAS (three subscales) and the BVAQ (five subscales). Equivalent subscales are shown side by side. Respondents must
indicate on a scale of one to five whether they strongly agree to strongly disagree (respectively) with each statement
20-Items TAS BVAQ-B
Difficulty identifying feelings: Poor insight:
I am often confused about what emotion I am feeling When I feel lousy, I know whether I am afraid or dejected or sad a
When I am upset, I don’t know if I am sad, frightened or angry When I am fed-up, it remains unclear to me whether I am sad or afraid or
unhappy
Difficulty describing feelings: Poor verbalising:
I find it hard to describe how I feel about people People often say that I should talk about my feelings
I am able to describe my feelings easily a I can express my feelings verbally a
Externally oriented thinking: Poor analysing:
I find examination of my feelings useful in solving personal problems a There is not much to understand as far as emotion are concerned
I prefer to watch ‘light’ entertainment shows rather than psychological
dramas
I think you should keep in tune with your feelings a
Poor fantasising:
I like to think up bizarre imaginative stories a
Fantasising about imaginary things or events is a waste of time, I think
Poor emotional excitability:
When I see somebody crying terribly, I remain unmoved
When friends around me argue furiously, I become emotional a
a Items that are negatively keyed.
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the scale (in which, 1 corresponded to “strongly agree”, and
5 to “strongly disagree”). This alteration was aimed at ho-
mogenising the presentation of the two alexithymia scales
used in our study. Scores on the TAS-20 and BVAQ-B range
from 20 to 100. For both self-reports, the scoring of the items
is such that high scores are indicative of a high proneness to
alexithymia.
2.1.1.2. Depression. The level of depression was assessed
using the 21-item BDI [9]. In this test individuals are asked to
respond to statements on the basis of how they have felt over
the past week. In this way the BDI provides an indication of
the presence of a depressive episode at the time of the study.
Scores on this scale range from 0 to 63.
2.2. General procedure
Questionnaires were given or sent out to participants at
two time points. Each time, full instructions were included as
well as stamped addressed envelopes for the return of the
questionnaires. Participants were encouraged to contact us if
they had questions concerning completion of the question-
naires. Responses from returned questionnaires were in-
cluded in the analysis only if the TAS-20 and BVAQ-B had
been completed fully at both time points and if responses on
these two scales were not confined to the “neither agree nor
disagree” response. One adult did not complete the BDI at
time point 1. The two test sessions were separated by
4–12 months. Ethics approval for the study had been ob-
tained from the ethics committee of University College
London/University College London Hospital.
3. Results
Mean total scores on the BVAQ-B, TAS-20 and BDI, as
well as mean scores for the cognitive and affective scores on
the BVAQ-B, and for each subscale of the BVAQ-B and
TAS-20 are shown in Table 1.
3.1. Test comprehension of the BVAQ-B
We examined how well the participants had understood
and completed the BVAQ-B. Given that it is a self-report
questionnaire, it is particularly important to establish this in a
clinical population, and especially in one such as ASD, since
this test has not been used previously with this population.
Of the original 32 adults with ASD who received the
questionnaires (test time 1), 27 (84.4%) returned them fully
completed. Only two of these 27 participants phoned us to
discuss the task instructions, which we had encouraged them
to do. These questions related solely to an uncertainty about
whether the BDI was concerned only with the preceding
week. No questions were asked about the meaning of items
on either the BVAQ-B or on the TAS-20 scales. All of the
participants who had completed the first study were con-
tacted again except for one who had requested not to be
involved in further research. Of these 26 individuals, 19
(73.1%) also participated in the second study. Of the remain-
ing seven, one refused to participate because of physical
illness at the time of contact, while two had moved without
leaving a forwarding address. The remaining four did not
respond to two attempts at contact. Of those 19 who chose to
participate in the second study, none contacted us to discuss
the task instructions at the second time of testing. Confidence
in the fact that this self-report questionnaire was completed
appropriately by the adults with ASD was strengthened by
the fact that these adults did not give the “I neither agree nor
disagree” response more often than the controls. Thus, the
ASD individuals appeared equally able to respond to ques-
tionnaires when asked to report about their own emotions as
the comparison group. Importantly in this respect, some
items of the BVAQ-B and TAS-20 are negatively keyed and
in order to get a high score (indicative of alexithymia) re-
spondents must be able to understand the questions and
switch their response from one question to another. Both
groups managed to respond successfully to both positively
and negatively keyed items, implying that both groups under-
stood what they were being asked to reply to, thereby sug-
gesting the rating scales were used appropriately in all cases.
A final hint that adds further support to the view the
participants’comprehension of the BVAQ-B was satisfactory
comes from the fact that some of the adults with ASD spon-
taneously sent letters to us along with their completed ques-
tionnaires. These letters described their difficulties and frus-
trations in the area of emotion processing. We quote
illustratively, and directly, from two of these letters. “I get so
mad when people say “got no feelings, can’t relate to me”. I
have feelings—told very deep...Trouble is wires crossed so
show all this in perhaps odd bizarre fashion or in misplaced
way.” (a 34-year-old woman with Asperger syndrome).
“When I am able to get people to understand me, my view of
life is positive, but when I am battling against the prejudice I
feel very low. This feeling comes from the powerlessness to
change my situation in which I find myself...In formal situa-
tions this is not a major problem, but in informal ones it is a
crushing one.” (a 31-year-old woman with Asperger syn-
drome).
3.2. Convergent validity
The convergent validity of the BVAQ-B was assessed by
comparing the responses of all participants (ASD and control
group together) on the BVAQ-B and the TAS-20 at each time
point. Pearson product moment correlations were conducted
to compare the total BVAQ-B and TAS-20 scores at test time
1 [r(60) = 0.62, P < 0.001] and test time 2 [r(46) = 0.45,
P < 0.001]. These analyses were repeated for the two partici-
pant groups separately [ASD time 1, r(25) = 0.77, P < 0.001;
ASD time 2, r(17) = 0.48, P < 0.05; control time 1,
r(33) = 0.41, P < 0.01; control time 2, r(27) = 0.31,
P = 0.056].
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Similarly, the equivalent subscales of the BVAQ-B and
TAS-20 were correlated at each time point, first for all par-
ticipants together: BVAQ-B ‘verbalising’versus TAS-20 ‘de-
scribing feelings’ [time 1, r(60) = 0.64, P < 0.001; time 2,
r(46) = 0.57, P < 0.001], BVAQ-B ‘identifying’ versus
TAS-20 ‘identifying feelings’ [time 1, r(60) = 0.72,
P < 0.001; time 2, r(46) = 0.65, P < 0.001] and BVAQ-B
‘analysing’ versus TAS-20 ‘externally oriented thinking’
[time 1, r(60) = 0.66, P < 0.001; time 2, r(46) = 0.65,
P < 0.001]. The correlations were repeated, considering each
group separately: BVAQ-B ‘verbalising’ versus TAS-20 ‘de-
scribing feelings’ [time 1: ASD, r(25) = 0.59, P < 0.001;
control, r(33) = 0.52, P < 0.001; time 2: ASD, r(17) = 0.46,
P < 0.05; control, r(27) = 0.14, P < 0.05], BVAQ-B ‘identi-
fying’ versus TAS-20 ‘identifying feelings’ [time 1: ASD,
r(25) = 0.71, P < 0.001; control, r(33) = 0.72, P < 0.001; time
2: ASD, r(17) = 0.55, P < 0.01; control, r(27) = 0.77,
P < 0.001], and BVAQ-B ‘analysing’ versus TAS-20 ‘exter-
nally oriented thinking’ [time 1: ASD, r(25) = 0.55, P < 0.01;
control, r(33) = 0.73, P < 0.001; time 2: ASD, r(17) = 0.67,
P < 0.05; control, r(27) = 0.49, P < 0.01]. Thus, there were
significant correlations between each equivalent factor at
both time points.
The cognitive score on the BVAQ-B was correlated with
total score on the TAS-20 at each test time. When all partici-
pants were included in the same analysis, there was a signifi-
cant correlation between these two scores at both tests [time
1, r(60) = 0.76, P < 0.001; time 2, r(44) = 0.67, P < 0.001].
Score on these two measures also correlated significantly at
both test times when the two groups were considered sepa-
rately [time 1: ASD, r(25) = 0.74, P < 0.001; control,
r(33) = 0.73, P < 0.001; time 2: ASD, r(17) = 0.66, P < 0.01;
control, r(27) = 0.47, P < 0.01].
Finally, for each self-report measure, Pearson product
moment correlations were used to investigate the association
between the total score and the subscale scores at each test
time. This analysis was applied to the ASD and control group
separately, as well as for both groups combined (see Table 3).
All but three comparisons achieved significance, with most
being at the P < 0.001 level. The exception to this was (i) at
test 2 in the ASD group, for the correlation between total
BVAQ-B and score on the emotionalising subscale; (ii) at test
1 in the control group, for the correlation between total
BVAQ-B score and score on the poor insight subscale; and
(iii) at test 2 in the control group for the correlation between
total TAS-20 score and score on the externally oriented
thinking subscale.
3.3. Discriminant validity
To test whether the BVAQ-B and the TAS-20 could dis-
criminate equally between the ASD and the control group,
total scores of each group on each test were compared. Since
both age and depression have been shown to be associated
with alexithymia in the general population [19,22,25], one
factor ANOVAs comparing age and BDI scores of the two
groups (ASD, control) were conducted. There was no signifi-
cant difference between the ages of the two groups at either
test time [time 1: F(1,59) = 0.92, P > 0.1; time 2:
F(1,46) = 1.55, P > 0.1]. There was a significant difference in
the intensity of depression in the two groups at both test times
[time 1: F(1,60) = 29.38, P < 0.001; time 2: F(1,46) = 8.82,
P < 0.01], reflecting significantly greater levels of depression
at the time of each test in the ASD adults. There was a
significant difference between the gender distribution across
the two groups at test 2 [v2(1) = 4.81, P < 0.05], with males
representing the greater proportion of the ASD group. This
difference was not significant at test 1 [v2(1) = 0.59, P > 0.1].
Given the size of the sample, statistical analysis was not
conducted on the subscales of each test. Since there was a
significant difference between the two groups in terms of the
intensity of depression at both test points and the gender
distributions at the second test, logistic regression analyses
adjusting for depression and gender were applied to the data
for the BVAQ-B and TAS-20 total scores at each test time
separately (with the total BDI score for the corresponding
test time included in the analysis). For the BVAQ-B there was
a significant difference between the two groups at test time 1,
with the ASD group exhibiting a significantly higher level of
alexithymia than the controls, once the level of depression
and participants’ gender had been controlled for
[Exp(B) = 1.09, CI (1.02–1.18), P < 0.02]. However, there
was no difference between the two groups at the second test
[Exp(B) = 1.05, CI (0.98–1.14), P = 0.17]. For the TAS-20,
Table 3
r and P values for Pearson product moment correlations between BVAQ-B
total score and each BVAQ-B subscores, as well as TAS-20 total score and
each TAS-20 subscores at time 1 and time 2. Shaded TAS-20 and BVAQ-B









Poor verbalising 0.75*** 0.63*** 0.74***
Poor fantasies 0.58** 0.72*** 0.60***
Poor insight 0.71*** 0.19 0.52***
Poor emotional excitability 0.66*** 0.63*** 0.65***
Poor analysing 0.79*** 0.79*** 0.81***
Time 2
Poor verbalising 0.62** 0.63*** 0.66***
Poor fantasies 0.61** 0.41* 0.47***
Poor insight 0.46* 0.62*** 0.59***
Poor emotional excitability 0.33 0.75*** 0.56***
Poor analysing 0.75*** 0.7*** 0.74***
TAS-20
Time 1
Difficulty identifying feelings 0.67*** 0.74*** 0.78***
Difficulty describing feelings 0.80*** 0.78*** 0.88***
Externally oriented thinking 0.67** 0.55*** 0.73***
Time 2
Difficulty identifying feelings 0.87*** 0.48** 0.79***
Difficulty describing feelings 0.84*** 0.61*** 0.84***
Externally oriented thinking 0.57** 0.27 0.58***
* P < 0.05; ** P < 0.01; *** P < 0.001.
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there was a significant difference between the two groups
once the level of depression and participants’ gender had
been controlled for, with the ASD group exhibiting a signifi-
cantly higher level of alexithymia than the controls. This was
the case at both test times [time 1, Exp(B) = 1.22, CI (1.09–
1.36), P < 0.001; time 2, Exp(B) = 1.17, CI (1.06–1.29),
P < 0.01].
The groups were compared on the cognitive score of the
BVAQ-B (i.e. the sum of the subscales verbalising, identify-
ing and analysing, taken to be equivalent to the TAS-20 total
score). A logistic regression analysis adjusting for depression
and gender was applied to the data at each test time sepa-
rately. At both test times there was a significant difference
between the groups [time 1, Exp(B) = 1.16, CI (1.04–1.3),
P < 0.01; time 2, Exp(B) = 1.13, CI (1.01–1.26), P < 0.05].
When using a logistic regression analysis to compare the
groups on the affective score of the BVAQ-B (i.e. the sum of
the subscales fantasising and emotionalising, aspects of al-
exithymia not included in the TAS-20), there was no signifi-
cant difference between the two groups at either test time,
after adjusting for depression and gender [time 1, Exp(B) =
1.1, CI (0.97–1.24), P = 0.13; time 2, Exp(B) = 0.99, CI
(0.84–1.17), P = 0.91].
Analysis and discussion of the TAS-20 and BDI scores for
an overlapping group of participants are given in more detail
elsewhere [17].
3.4. Test–retest reliability
Test–retest reliability was assessed using Pearson product
moment correlations [24]. Correlations were conducted on
the responses at test 1 versus test 2 for the two groups
separately, as well as for all participants together for
BVAQ-B total, TAS-20 total, each of the five BVAQ-B sub-
scales and each of the three TAS-20 subscales. The results are
given in Table 4. Most correlations were significant at the
P < 0.001 level. In the ASD group, correlation values for the
BVAQ-B and the TAS-20 scores and subscores ranged be-
tween 0.62–0.82 and 0.79–0.92, respectively. In the control
group, correlation values for the BVAQ-B and the TAS-20
scores and subscores ranged between 0.20–0.67 and 0.29–
0.72, respectively. Taking a test–retest reliability value of
r ≥ 0.70 to be considered satisfactory (see [20]), the TAS-20
showed a more consistent degree of reliability for both the
total, and individual subscale scores in all groupings analy-
sed in comparison to the BVAQ-B.
4. Discussion
The focus of the current paper was on the validity of using
self-reports to assess emotion regulation abilities in ASD. To
assess this we sought responses to the BVAQ-B and TAS-20
at two time points from individuals with and without ASD.
The test comprehension of the BVAQ-B in our ASD
sample was good, as it was on the TAS-20 suggesting, in line
with Baron-Cohen et al. [7] that high-functioning individuals
with ASD are able to respond adequately to self-report ques-
tionnaires. Furthermore, the convergent validity of the
BVAQ-B with the TAS-20 was good. In accordance with
previous studies that have used the TAS-20 as a gold standard
[11,23,31,32], the present results support the validity of the
BVAQ-B as an alexithymia questionnaire for investigation of
clinical population.
It is generally agreed that the TAS-20 should not be used
in isolation in an assessment for alexithymia [20,30]. In our
study, as in previous studies, the TAS-20 discriminated
clearly between a clinical and non-clinical sample (see [28]
for a recent review). However, this difference was not mir-
rored so clearly in responses to the BVAQ-B. The uneven
profile of group discrimination on the BVAQ-B was rather
unexpected since the differences between the two groups
were striking on the TAS-20. This was unexpected since the
BVAQ-B includes two factors that are missing from the
TAS-20 (fantasising and emotionalising) and for which we
had expected higher scores in the ASD than in the control
group. Bermond (1997) has suggested two kinds of al-
exithymia that may be distinguished [10]. Type I alexithymia
is characterised by a low degree of conscious awareness of
emotional arousal and a low degree of emotion accompany-
ing cognitions. Type II alexithymia is characterised by a
normal or high degree of conscious awareness of emotional
arousal together with a low degree of accompanying cogni-
tions. As pointed out by Vorst and Bermond (2001), the
BVAQ can be used to distinguish these two types of al-
exithymia ([31], p. 432). The use of the BVAQ-B in our ASD
population suggested that this group was more specifically
impaired on the cognitive dimensions of alexithymia
(i.e. identifying,verbalizing and analysing), corresponding to
Type II alexithymia in Bermond’s account [10].
This is the first study, not only to investigate the test–retest
reliability of the BVAQ-B in any sample, but also to consider
TAS-20 test–retest reliability in both a clinical and a non-
Table 4
Pearson product moment correlations and P values for scores at test 1 versus
test 2 for the ASD and comparison groups separately, as well as for all
participants together for BVAQ-B total, TAS-20 total, the five BVAQ-B
subscores and the three TAS-20 subscores. Shaded BVAQ-B and TAS-20










BVAQ-B total 0.81** 0.32 0.59**
Poor verbalising 0.82** 0.35 0.67**
Poor fantasies 0.66** 0.56* 0.59**
Poor insight 0.63* 0.67** 0.67**
Poor emotional excitability 0.62* 0.22 0.39*
Poor analysing 0.72** 0.20 0.70**
TAS-20 total 0.92** 0.29 0.80***
Difficulty identifying feelings 0.81** 0.70** 0.82**
Difficulty describing feelings 0.79** 0.65** 0.82**
Externally oriented thinking 0.86** 0.72** 0.82**
* P < 0.01; ** P < 0.001.
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clinical sample over such a long period (intervals of
4–12 months). In the ASD group, the test–retest reliability of
the TAS-20 was good for both the total score on this scale and
its subscales. This was also the case when all the participants
were combined (but marginally less so for the control group
alone). Whereas Kooiman et al. found that only the ‘difficulty
to identify feelings’ subscore had a test–retest reliability that
reached the conventional level of adequacy [20], all the
TAS-20 factors showed a satisfactory level of adequacy in
our clinical group. For the BVAQ-B, test–retest reliability
was also satisfactory: for the ‘poor analysing’ subscore for
the ASD group and when all participants were combined; and
for the BVAQ-B total and ‘poor verbalising’ subscore for the
ASD participants.
As far as we are aware, this is the first set of studies to
address directly the presence of alexithymia in an ASD popu-
lation. Our investigations suggest that it is possible to reliably
identify alexithymia in this population, since individuals
with ASD appeared capable of responding adequately to
questionnaires when asked to report their own emotions.
Furthermore, test–retest reliability was stable over time in
this population, with the caveat of the BVAQ-B in the control
group. Taken together, the findings of our two studies [17]
suggest that we have identified a tool to understand better the
experiences of individuals with ASDs, adding to information
from case reports of individuals with ASD who others have
identified and treated successfully for depression [21]. Fur-
thermore these suggestions are supported by autobiographi-
cal accounts of apparently well-compensated individuals
with ASDs which indicate an ability to report own feelings,
although these are reported in an unusual way (e.g. [13,14]).
Thus, despite the fact that individuals with ASD are com-
monly believed to have difficulty processing their own and
other people’s emotions, we have shown that with regards to
own emotion processing, it is more likely that individuals
with ASD show a different way of actually processing their
emotions, rather than an absence of this processing. It should
be stressed that these arguments relate only to the processing
of own, rather than other people’s emotions. Further discus-
sion of the existence of alexithymia in an ASD population
can be found elsewhere [17].
5. Conclusion
In sum, our study suggests that emotion regulation self-
report questionnaires can be used to characterise the ASD
affective style. ASD participants appeared more depressed
and more alexithymic (even when taking their increased level
of depression into account, as it has been demonstrated that
depression can constitute a confounding variable when mea-
suring alexithymia). We should be cautious though, since our
sample was relatively small. However the results can be
considered reasonable in light of the report by Baron-Cohen
et al. [7] that the test–retest reliability of their self-report
measure, the autism spectrum quotient, was good in a sample
of 17 adults with ASD. Further work is needed to replicate
our effect, not only in a larger sample of ASD individuals, but
also in other clinical populations, something that we are
undertaking currently. Use of the alexithymia questionnaires
highlighted that high-functioning adults with ASD were able
to reflect on their own emotions, but that they have an in-
creased likelihood of experiencing the cognitive impairments
characteristic of alexithymia in comparison to a non-clinical
adult control group. However, in the light of the findings
presented here, we argue, in accordance with other authors
[20,30], that alexithymia self-reports should be used con-
jointly with other measures when assessing alexithymia. In
particular, the Observer Alexithymia Scale would be a useful
addition. This scale appears to be promising for collecting
and evaluating observer data on alexithymia in clinical
samples [16].
Acknowledgements
This research was supported by funding from the Medical
Research Council (UK; grant number G9716841). We grate-
fully acknowledge the willing participation of all individuals
in this study and Professor Mark Haviland for invaluable
comments on an earlier draft of the paper.
References
[1] Bagby RM, Taylor GJ. Measurement and validation of the
alexithymia construct. In: Taylor GJ, Bagby RM, Parker JDA, editors.
Disorders of affect regulation: alexithymia in medical and psychiatric
illness. Cambridge: Cambridge University Press; 1997. p. 46–66.
[2] Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto
alexithymia scale-I. Item selection and cross-validation of the factor
structure. J Psychosom Res 1994a;38:23–32.
[3] Bagby RM, Taylor GJ, Parker JDA. The twenty-item Toronto
alexithymia scale-II. Convergent, discriminant, and concurrent valid-
ity. J Psychosom Res 1994b;38:33–40.
[4] Baron-Cohen S. The extreme male brain theory of autism. TICS
2002;6:248–54.
[5] Baron-Cohen S, Tager-Flusberg H, Cohen D. Understanding other
minds. Perspectives from autism. Oxford: Oxford University Press;
1993.
[6] Baron-Cohen S, Tager-Flusberg H, Cohen D. Understanding other
minds. Perspectives from developmental neuroscience. Oxford:
Oxford University Press; 2000.
[7] Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The
autism-spectrum quotient (AQ): evidence from Asperger
syndrome/high-functioning autism, males and females, mathemati-
cians and scientists. J Autism Dev Disord 2001;31:5–17.
[8] Baron-Cohen S, Richler J, Bisarya D, Gurunathan N, Wheelwright S.
The systemizing quotient: an investigation of adults with Asperger
syndrome or high-functioning autism and normal sex differences.
Philos Trans R Soc Lond B Biol Sci 2003;358:361–74.
[9] Beck AT, Steer R, Garbin M. Psychometric properties of the Beck
depression inventory: 25 years of research. Clin Psychol Rev 1988;8:
77–100.
[10] Bermond B. Brain and alexithymia. In: Vingerhoets A, Bussel F,
Boelhouwer J, editors. The (non)expression of emotions in health and
disease. Tilburg, The Netherlands: Tilburg University Press; 1997.
p. 115–30.
297S. Berthoz, E.L. Hill / European Psychiatry 20 (2005) 291–298
[11] Berthoz S, Ouhayoun B, Perez-Diaz F, Consoli SM, Jouvent R.
Comparison of the psychometric properties of two self-report ques-
tionnaires measuring alexithymia: confirmatory analysis of the
20-item Toronto alexithymia scale and the Bermond–Vorst
alexithymia questionnaire. Eur Rev Appl Psychol 2000;50:359–68.
[12] Frith U. Autism: explaining the enigma. 2nd ed. Oxford: Blackwell
Publishing; 2003.
[13] Gerland G. A real person: life on the outside [Tate J, Trans.]. London:
Souvenir; 1997.
[14] Grandin T, Scariano MM. Emergence labelled autistic. Bodmin:
Costello; 1986.
[15] Haviland MG, Reise SP. A California Q-set alexithymia prototype and
its relationship to ego-control and ego-resiliency. J Psychosom Res
1996;41:597–608.
[16] Haviland MG, Warren WL, Riggs ML, Gallacher M. Psychometric
properties of the observer alexithymia scale in a clinical sample. J Pers
Assess 2001;77:176–86.
[17] Hill E, Berthoz S, Frith U. Cognitive processing of own emotions in
individuals with autistic spectrum disorder and their relatives. J
Autism Dev Disord 2004;4:229–35.
[18] Hobson RP. Autism and the development of mind. Hove, HK:
Lawrence Erlbaum; 1993.
[19] Honkalampi K, Hintikka J, Tanskanen A, Lehtonen J, Viinamäki H.
Depression is strongly associated with alexithymia in the general
population. J Psychosom Res 2000;48:99–104.
[20] Kooiman CG, Spinhoven P, Trijsburg RW. The assessment of
alexithymia. A critical review of the literature and a psychometric
study of the Toronto alexithymia scale-20. J Psychosom Res 2002;53:
1083–90.
[21] Lainhart JE, Folstein S. Affective disorders in people with autism: a
review of published cases. J Autism Dev Disord 1994;24:587–601.
[22] Lane RD, Sechrest L, Riedel R. Sociodemographic correlates of
alexithymia. Compr Psychiatry 1998;39:377–85.
[23] Müller J, Bühner M, Ellgring H. The assessment of alexithymia:
psychometric properties of the Bermond–Vorst alexithymia question-
naire. Pers Indiv Diff 2004 [in press].
[24] Rousson V, Gasser T, Seifert B. Assessing intrarater, interrater and
test–retest reliability of continuous measurements. Stat Med 2002;21:
3431–46.
[25] Salminen JK, Saarijarvi S, Aarela E, Toikka T, Kauhanen J. Preva-
lence of alexithymia and its association with sociodemographic vari-
ables in the general population of Finland. J Psychosom Res 1999;46:
75–82.
[26] Sifnéos PE. The prevalence of alexithymic characteristics in psycho-
somatic patients. Psychother Psychosom 1973;22:255–62.
[27] Sifnéos PE.Alexithymia: past and present.Am J Psychiatry 1996;153:
137–42.
[28] Taylor GJ. Recent development in alexithymia theory and research.
Can J Psychiatry 2000;45:134–42.
[29] Taylor GJ, Ryan D, Bagby RM. Toward the development of a new
self-report alexithymia scale. Psychother Psychosom 1985;44:191–9.
[30] Taylor GJ, Bagby RM, Parker JDA. Disorders of affect regulation:
alexithymia in medical and psychiatric illness. Cambridge: Cam-
bridge University Press; 1997.
[31] Vorst HCM, Bermond B. Validity and reliability of the Bermond–
Vorst alexithymia questionnaire. Pers Indiv Diff 2001;30:413–34.
[32] Zech E, Luminet O, Rime B, Wagner H. Alexithymia and its
measurement: confirmatory factor analyses of the twenty-item Tor-
onto alexithymia scale and the Bermond–Vorst alexithymia question-
naire. Eur J Pers 1998;13:511–32.
298 S. Berthoz, E.L. Hill / European Psychiatry 20 (2005) 291–298
